ArticleACS medicinal chemistry letters2026

Novel Compounds with Aryl Linkers as Glucagon Receptor Agonists for Treating Type 2 Diabetes Mellitus and Obesity.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.